Japan-based pharmaceutical company focused on the manufacturing and distribution of pharmaceuticals.
Shionogi & Co., Ltd. is a Japan-based pharmaceutical company engaged in the research, development, purchase, manufacture, and sale of pharmaceuticals, as well as pharmaceutical-related businesses. Shionogi's research scientists have discovered therapeutics including naldemedine, rosuvastatin and dolutegravir, and are currently working on many more potential future products. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.
Shionogi group is made up of 11 companies based in Japan, and 6 more based in Taiwan, USA, Hong Kong, United Kingdom, China, and Singapore.